Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of Shareholders

          Cardiol Therapeutics Reports Results of 2024 Annual General and Special Meeting of ShareholdersJune 27, 2024 12:29 PM EDT | Source: Cardiol Therapeutics Inc.Toronto, Ontario--(Newsfile Corp. - June 27, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, announces the results from its a ...